Colombian epidemiologist whose IARC studies proved HPV causes cervical cancer and identified the types the vaccines target.
Nubia Muñoz led the IARC multicentre case-control studies across four continents that established human papillomavirus as the necessary cause of cervical cancer and the 2003 classification of high-risk HPV types that determined which types the prophylactic vaccines should cover. She was a principal investigator in the Costa Rica and quadrivalent vaccine trials and received the Gairdner Global Health Award.
| Title | Journal | Year |
|---|---|---|
| Epidemiologic classification of human papillomavirus types associated with cervical cancer | NEJM | 2003 |
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Journal of Pathology | 1999 |
| Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17 | New England Journal of Medicine | 2020 |
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, International Agency for Research on Cancer (IARC / WHO), HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer and the tags hpv, epidemiology.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer and the tags hpv, prevention.
Shares International Agency for Research on Cancer (IARC / WHO), HPV & HBV vaccination, Cervical cancer.
Shares International Agency for Research on Cancer (IARC / WHO), HPV & HBV vaccination, Cervical cancer.
Shares Cervical cancer and the tags epidemiology, prevention.
Shares HPV & HBV vaccination, Cervical cancer and the tag prevention.